Table 1 Clinical and Demographic Characteristics of HCC Patients
From: Molecular characterization of plasma virome of hepatocellular carcinoma (HCC) patients
Sr. No | Characteristics | N (%) |
|---|---|---|
1 | Gender | |
2 | Male | 276/381 (72.4) |
3 | Female | 105/381 (27.6) |
Age wise | ||
5 | 18–30 | 70/381 (18.4) |
6 | 31–45 | 86/381 (22.6) |
7 | 46–60 | 121/381 (31.8) |
8 | 61- above | 104/381 (27.3) |
Etiology | ||
10 | HCV | 291/381 (76.4) |
11 | HBV | 44/381 (11.5) |
12 | HCV + HBV | 17/381 (4.5) |
13 | NASH | 13/381 (3.4) |
14 | Non HCV/HBV | 16/381 (4.2) |
MELD score | ||
16 | < 10 | 204/381 (53.5) |
17 | 11–20 | 153/381 (40.2) |
18 | 21–30 | 19/381 (5) |
19 | 31–40 | 05/381 (1.3) |
ECOG status | ||
21 | Fully active | 17/381 (4.5) |
22 | Restricted physical activity, able to do sedentary work | 301/381 (79) |
23 | Ambulatory capable of self-care, unable to carry out any work activities | 46/381 (12.1) |
24 | Self-limited care on chair more than 50% working hours | 12/381 (3.1) |
25 | Completely disable cannot carry on any self-care | 05/381 (1.3) |
Child Pugh Score | ||
27 | A | 113/381 (29.6) |
28 | B | 172/381 (45.2) |
29 | C | 96/381 (25.2) |
BCLC stage | ||
31 | 0 | 13/381 (3.4) |
32 | A | 57/381 (15) |
33 | B | 193/381 (50.7) |
34 | C | 106/381 (27.8) |
35 | D | 12/381 (3.1) |